Latikafusp represents a novel medical strategy for managing certain cancers, particularly instances involving fusion ALK proteins. This drug functions as an repressor of truncated anaplastic lymphoma kinase structures, demonstrating promise in laboratory investigations and initial patient studies. Its mechanism of function offers a specific meth… Read More